188 related articles for article (PubMed ID: 9079740)
1. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.
Ravery V; Grignon D; Angulo J; Pontes E; Montie J; Crissman J; Chopin D
Urol Res; 1997; 25(1):9-17. PubMed ID: 9079740
[TBL] [Abstract][Full Text] [Related]
2. Oncoprotein changes in the flat lesions with atypia and invasive neoplasms of the urinary bladder.
Kee KH; Lee MJ; Ro JY
Oncol Rep; 2001; 8(3):579-83. PubMed ID: 11295084
[TBL] [Abstract][Full Text] [Related]
3. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
Türkeri LN; Erton ML; Cevik I; Akdaş A
Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
6. Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells.
De Boer WI; Houtsmuller AB; Izadifar V; Muscatelli-Groux B; Van der Kwast TH; Chopin DK
Int J Cancer; 1997 Apr; 71(2):284-91. PubMed ID: 9139855
[TBL] [Abstract][Full Text] [Related]
7. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.
Rajkumar T; Stamp GW; Pandha HS; Waxman J; Gullick WJ
J Pathol; 1996 Aug; 179(4):381-5. PubMed ID: 8869284
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
Hofmockel G; Riess S; Bassukas ID; Dämmrich J
Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
[TBL] [Abstract][Full Text] [Related]
10. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E
Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor and bladder cancer: a review.
Neal DE; Mellon K
Urol Int; 1992; 48(4):365-71. PubMed ID: 1357809
[TBL] [Abstract][Full Text] [Related]
12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
13. HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.
Moustakas G; Kampantais S; Nikolaidou A; Vakalopoulos I; Tzioufa V; Dimitriadis G
J Int Med Res; 2020 Jan; 48(1):300060519895847. PubMed ID: 31937176
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
17. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
[TBL] [Abstract][Full Text] [Related]
18. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.
Neal DE; Marsh C; Bennett MK; Abel PD; Hall RR; Sainsbury JR; Harris AL
Lancet; 1985 Feb; 1(8425):366-8. PubMed ID: 2857420
[TBL] [Abstract][Full Text] [Related]
19. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
[TBL] [Abstract][Full Text] [Related]
20. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
